Irhythm Technologies, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
February 25, 2021 at 04:05 pm EST
Share
iRhythm Technologies, Inc. announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced sales was USD 78.809 million compared to USD 59.104 million a year ago. Operating loss was USD 9.581 million compared to USD 17.726 million a year ago. Net loss was USD 9.651 million compared to USD 17.300 million a year ago. Basic loss per share from continuing operations was USD 0.33 compared to USD 0.65 a year ago. For the full year, sales was USD 265.166 million compared to USD 214.552 million a year ago. Operating loss was USD 43.673 million compared to USD 54.755 million a year ago. Net loss was USD 43.830 million compared to USD 54.568 million a year ago. Basic loss per share from continuing operations was USD 1.58 compared to USD 2.16 a year ago.
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
IRHYTHM TECHNOLOGIES, INC. 
